Search Results - "Metintas, Muzaffer"

The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer by Gul, Busra, Metintas, Selma, Ak, Guntulu, Yilmaz, Senay, Metintas, Muzaffer

“…Purpose The study aimed to determine the poor nutritional status, related factors, and its effect on the prognosis of patients with locally advanced and…”
Get full text

Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy by Batirel, Hasan Fevzi, MD, PhD, Metintas, Muzaffer, MD, Caglar, Hale Basak, MD, Ak, Guntulu, MD, Yumuk, Perran Fulden, MD, Yildizeli, Bedrettin, MD, Yuksel, Mustafa, MD

“…Abstract Objective We changed our surgical approach to malignant pleural mesothelioma (MPM) in August 2011 and adopted pleurectomy and decortication (PD)…”
Get full text

What has changed in malignant mesothelioma between 1990 and 2019? A time- series analyses in Turkey by Metintas, Selma, Ak, Guntulu, Dundar, Emine, Metintas, Muzaffer

“…Objectives To investigate the changes in epidemiological and survival characteristics of malignant mesothelioma (MM) cases diagnosed in a 30-year period…”
Get full text

Potential years of life and productivity loss due to malignant mesothelioma in Turkey by Metintas, Selma, Ak, Guntulu, Metintas, Muzaffer

“…The study aimed to calculate years of life lost (YLL) and years of potential life lost (YPLL) due to malignant mesothelioma (MM) in Turkey. YLL was computed by…”
Get full text

Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program by Metintaş, Selma, Batırel, Hasan Fevzi, Bayram, Hasan, Yılmaz, Ülkü, Karadağ, Mehmet, Ak, Güntülü, Metintaş, Muzaffer

“…Malignant mesothelioma (MM) is an important health problem due to ongoing asbestos exposure. Environmental asbestos exposure leads to a high risk of MM in…”
Get full text

Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study by Yakar, Melek, Etiz, Durmus, Metintas, Muzaffer, Ak, Guntulu, Celik, Ozer

“…Background: Radiation pneumonitis (RP) is a dose-limiting toxicity in lung cancer radiotherapy (RT). As risk factors in the development of RP, patient and…”
Get full text

Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study by Yildirim, Huseyin, Metintas, Muzaffer, Entok, Emre, Ak, Guntulu, Ak, Ilknur, Dundar, Emine, Erginel, Sinan

“…Several studies have already addressed the potential role of an increased fluorine 18 fluorodeoxyglucose (18F FDG) uptake in identification of pleural…”
Get more information

Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma by Akgun, Hakan, Metintas, Selma, Ak, Guntulu, Demirkol Canlı, Secil, Isbilen, Murat, Gure, Ali O, Metintas, Muzaffer

“…The prognosis of malignant pleural mesothelioma (MPM) is poor, with a limited survival time. In this study, we aimed to examine expression levels of genes…”
Get full text

Evaluation of the contribution of fine-needle non-aspiration cytology to diagnosis in cases with pulmonary malignant lesions by Yılmaz, Şenay, Ak, Güntülü, Metintaş, Selma, Dündar, Emine, Metintaş, Muzaffer

“…Fine-needle non-aspiration cytology (FNNAC) is an easy-to-apply, minimally invasive diagnostic method that contributes to the diagnosis and staging of lung…”
Get full text

Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma by Mundt, Filip, Johansson, Henrik J., Forshed, Jenny, Arslan, Sertaç, Metintas, Muzaffer, Dobra, Katalin, Lehtiö, Janne, Hjerpe, Anders

“…Malignant mesothelioma is an aggressive asbestos-induced cancer, and affected patients have a median survival of approximately one year after diagnosis. It is…”
Get full text

Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma by Mundt, Filip, Nilsonne, Gustav, Arslan, Sertaç, Csürös, Karola, Hillerdal, Gunnar, Yildirim, Huseyin, Metintas, Muzaffer, Dobra, Katalin, Hjerpe, Anders

“…Diagnosis of malignant mesothelioma is challenging. The first available diagnostic material is often an effusion and biochemical analysis of soluble markers…”
Get full text

Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study by Ak, Guntulu, Metintas, Selma, Taskın, Ayse Naz, Uzel Sener, Melahat, Soyler, Yasemin, Yilmaz, Meltem, Turna, Akif, Akin Kabalak, Pınar, Bilaceroglu, Semra, Koksal, Deniz, Yilmaz Demirci, Nilgun, Sogukpinar, Ozlem, Boga, Sibel, Ercelik, Merve, Karadeniz, Gulistan, Polat, Gulru, Guldaval, Filiz, Aka Akturk, Ulku, Yilmaz, Senay, Ogan, Nalan, Yilmaz, Saliha, Esendagli, Dorina, Caglayan, Benan, Zeybek, Arife, Durmus Kocak, Nagihan, Mutlu, Pinar, Atinkaya Baytemir, Cansel, Sarbay, Ismail, Yilmaz, Ulku, Metintas, Muzaffer

“…Purpose The aim of this study is to determine the diagnostic performances of pleural procedures in undiagnosed exudative pleural effusions and to evaluate…”
Get full text

Prediction of Survival and Progression-free Survival Using Machine Learning in Stage III Lung Cancer: A Pilot Study by yakar, melek

Get full text

Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies by Mundt, Filip, Heidari-Hamedani, Ghazal, Nilsonne, Gustav, Metintas, Muzaffer, Hjerpe, Anders, Dobra, Katalin

“…Background. The distinction between malignant and benign pleural effusions is a diagnostic challenge today and measuring soluble biomarkers could add to the…”
Get full text

Analysis of Epidemiological, Clinical and Laboratory Characteristics of Patients with Pleural Effusion by Yilmaz, Senay, Yildirim, Huseyin, Ak, Guntulu, Metintas, Selma, Bogar, Filiz, Metintas, Muzaffer

“…Objectives: The clinical features of the patients with pleural effusion (PE) may vary according to geographic areas. The aim of this study was to determine the…”
Get full text

Prognostic factors according to the treatment schedule in malignant pleural mesothelioma by Ak, Guntulu, Metintas, Selma, Metintas, Muzaffer, Yildirim, Huseyin, Erginel, Sinan, Kurt, Emel, Alatas, Fusun, Cadirci, Omer

“…In this study, we aimed to investigate the factors affecting the survival of patients with malignant pleural mesothelioma (MPM) according to their treatment…”
Get more information

Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma by Ak, Guntulu, Metintas, Muzaffer, Metintas, Selma, Yildirim, Huseyin, Ozkan, Ragip, Ozden, Hilmi

“…Abstract Objectives Measurement of tumor response to chemotherapy in malignant pleural mesothelioma (MPM) is problematic because of non-spherical tumor growth…”
Get full text

The safety of medical thoracoscopy in a group at high risk for complications by Metintas, Muzaffer, Ak, Guntulu, Yildirim, Huseyin, Danacioglu, Serpil, Dundar, Emine, Metintas, Selma

“…The use of medical thoracoscopy (MT) for the diagnosis and/or palliative treatment of pleural effusions is expected to become more widespread in the coming…”
Get full text

Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography by Değirmenci, Nevbahar Akcar, Metintaş, Muzaffer, Atlanoglu, Sahinde, Yıldırım, Huseyin

“…Objective The aim of the study was to evaluate the renal resistive index (RI) and pulsatility index (PI) in patients with pleural effusion (PE). Materials and…”
Get full text

Vascular endothelial growth factor levels in active pulmonary tuberculosis by Alatas, Füsun, Alatas, Ozkan, Metintas, Muzaffer, Ozarslan, Aysen, Erginel, Sinan, Yildirim, Hüseyin

“…Vascular endothelial growth factor (VEGF) is a mediator with potent angiogenic, mitogenic, and vascular permeability-enhancing activities that are specific for…”
Get more information